Journal of Heart and Lung Transplantation

Article	Citations
Information for Readers	551
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	376
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes	364
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD	224
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience	168
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation	168
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients	89
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade	85
Extending the Transplant Practitioner Role within the National Organ Retrieval Team to Include Organ Care Practitioner	82
Using Donor Lungs ≥70 Years of Age for Transplantation - Do Long-Term Outcomes Justify the Use?	79
Heart Transplantation Utilizing Organs Following Donation After Circulatory Death (DCD)	79
(715) Diaphragm Dysfunction from Covid-19 Phrenic Neuropathy: Utilization of Diaphragm Pacing for Recovery	72
(849) The Utility of Mechanical Circulatory Support in the Management of Massive Pulmonary Embolism with Right Ventricular Failure	61
(797) Implantation from Short Term MCS to Durable VAD: Single Center Experience	60
(904) Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes	59
(782) Use of Extracorporeal Membrane Oxygenation in Ranolazine Overdose	56
Predictors of Failure to Rescue After Left Ventricular Assist Device Implantation	56
Predictors of One-Year Outcome in Patients Undergoing Cardiac Re-Transplantation: Machine Learning Analysis	55
(1033) Effect of Practice Variation Amongst Organ Procurement Organizations on Pediatric Donor Heart Utilization	53
Hemodynamic Modeling for Mitral Regurgitation	53
Early Mammalian Target of Rapamycin Inhibitor Utilization After Heart Transplantation: Analysis of the UNOS Database	51
(811) Incidence of Right Ventricular Dysfunction in Lvad Patients Bridged with High Dose Inotropes	50
Polymicrobial and Multiple Blood Stream Infection Episodes as Risk Factors for On-Pump Mortality in Mechanical Circulatory Support Patients	50
(120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience	49
(908) Does Donor-Recipient Sex Mismatch Have an Influence on Long Term Outcomes after Lung Transplantation? An Experience of a High Volume Center	49

(1270) Thermal Preconditioning During EVLP Reduces T Lymphocytes and Increases Monocytes and Neutrophils Contents in the Perfusion Solution	46
ISHLT 2023 Author Index	45
(384) Urine Exosomes for Kidney Health Assessment in Mechanical Circulatory Support	45
(151) Plasma Proteomic Signature of Human Heart Transplant Recipients After Restoration of Blood Circulation and Its Relationship to Graft Outcome	45
(742) Prognostic Value of Donor Specific Human Leukocyte Antibodies in Pre-Sensitized Heart Transplant Patients	44
(1153) Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant	43
Challenges in Heart Transplantation During COVID-19 Pandemic in Brazil	41
(1188) Assessment of Dd-cfDNA Between Stable Single and Double Lung Recipients	41
Use of a Medication Questionnaire to Identify Lung Transplant Recipients Benefiting from Pharmacist Prioritization in Clinic	40
(1206) Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients	40
(1226) Serum Proteomics for Fibrotic Markers in Early Detection of Bronchiolitis Obliterans Syndrome after Lung Transplantation	40
(1215) Think Inside The Box: Constrictive Pericarditis after Pediatric Lung Transplant	40
(472) Giant Cell Myocarditis with LVAD Presenting with Acute Severe AI Managed with Valve-In-Valve TAVI	39
Pulmonary Hypertension and Diastolic Heart Failure in an Adolescent African-American Cantú Syndrome Patient	38
Argon Inhalation Reduces Pulmonary Ischemia-Reperfusion Injury in MHC-inbred CLAWN Miniature Swine	38
When a Single Choice Impacts a Single Ventricle: Paracorporeal Pediatric VAD Support at 544 Days	37
Hypogammaglobinemia in Patients Palliated with the Fontan Circulation: Implications for Cardiac Transplantation	36
The Normalised Acute Rejection Score in the First Year Post Transplant and Its Association with CLAD	36
Comparison of LVAD Admissions Before and During the Era of COVID-19	36
(854) Effect of Dobutamine on Rv Contractility and Rv-Pa Coupling in the Normal Rv	35
Sequential Double-Lung Transplantation in Kartagener Syndrome: A Case Report	35
Bedside Ultrasound of Internal Jugular Vein for Right Ventricular Function Assessment	34
(911) Older Donors in Lung Transplantation: The Portuguese Experience	34
Hemodynamic Implications of Sildenafil in Candidates for Heart Transplantation with Group 2 Pulmonary Hypertension: A Single Latin-American Center Registry	33
Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Use in Patients with Left-Ventricular Assist Device: Validation of the VT-LVAD Prediction Score	31
Safety of Single Lung Transplantation Post Donation Service Area-Specific Organ Distribution	31
(888) Initiating an ECMO Program at a Safety Net Hospital During a Global Pandemic	30
Immune Characterization of a Xenogeneic Cross Circulation System for Ex Vivo Human Lung Support	30
Kidney Transplantation in Single Ventricle Palliated Patients: A Pediatric Cardiac Care Consortium Study	30
Decoupling Between Pulmonary Artery Diastolic and Wedge Pressure Following TAVR	30
Oral Aversion and Its Risks in Pediatric Heart Transplant Recipients	30
Utility of Breath Volatomic Analysis in Lung Transplant Recipients	29
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome	29
Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study	29
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients	29
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status	29
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience	28
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis	28
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	28
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models	28
Information for Readers	28
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation	28
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD	28
Not just for the birds: The emerging role of B cells in transplant immunology	27
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation	26
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial	26
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients	26
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients	25
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System	25
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy	25

Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass	25
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing	25
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation	25
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant	25
Older Donor Hearts for Heart Transplantation	24
Comparative Analysis of Fontan Transplant Outcomes	24
WITHDRAWN	24
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension	24
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil	24
Early Onset Malignancy in the First-Year After Heart Transplantation	24
Organ Care System (OCS) Perfusion Time During Donation After Circulatory Death (DCD) Heart Transplantation: Not Too Little, Not Too Much: There Safety Lie	23
Table of Contents	23
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation	23
Cardiac Tamponade Associated to an Early EBV-Induced Lymphoma After Heart Transplantation: A Case Report	23
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation	23
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support	23
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series	23
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis	23
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients	23
Cardiac output assessment methods in left ventricular assist device patients: A problem of heteroscedasticity	22
Lactic Acid and Metabolic Analysis of Human Donor Hearts Preserved with Organ Care System	22
Do Temporary Mechanical Circulatory Support Devices Activate Sensitization Pathways in Patients Awaiting Heart Transplantation?	22
Recurrence of pulmonary arterial hypertension 32 months after bilateral lung transplant	22
Evaluating age-based eligibility thresholds for heart re-transplantation – an analysis of the united network for organ sharing database	22
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial	22
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation	22
Ex-vivo lung perfusion: National trends and post-transplant outcomes	22
Alveolar macrophage subsets: Accessories to lung alloimmune rejection	22
Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing	22
Imaging Mass Cytometry for Detailed Cellular and Spatial Characterization of Chronic Lung Allograft Dysfunction (CLAD)	22
Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection	21
Extra-cardiac management of cardiogenic shock in the intensive care unit	21
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients	21
Center volume effect on acute cellular rejection and outcomes in pediatric lung transplant recipients	21
Post Transplant Malignancy Risk Factors in Thoracic Solid Organ Transplant Recipients	20
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection	20
Contemporary outcomes of mechanical circulatory support using paracorporeal continuous flow pump in children: A report from the ACTION learning network	20
INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION:EVOLUTION OF PROGNOSIS IN 10 YEARS OF NEW EMERGING THERAPIES	20
Impact of Donor Transfusions on Lung Transplant Outcomes: A National Cohort Analysis	20
What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis	20
DCD heart transplantation with NRP: Excellent results and a continued uphill battle	20
Activation of cGAS-Dependent Necroptosis during Cold Static Preservation of Lungs Relies on Calcium	20
An Uncommon Driver of Waitlist Urgency: Recurrent Secondary Spontaneous Pneumothoraces of the Lung Allograft in a Single Lung Transplant (SLT) Recipient with CLAD	20
Extending the bridge, bridging the gap	20
MINIMALLY INVASIVE PULMONARY ENDARTERECTOMY THROUGH INVERTED-T UPPER HEMISTERNOTOMY	20
Use of Heart in Donor Death Caused by Lightning	19
Midterm Outcomes in Orthotopic Heart Transplant Recipients with a History of Methamphetamine Use	19
Influence of Risk Factors on PTLD-Free Probability in Lung Transplant Patients: SRTR Database Analysis	19
A Single Centre Review of INR Monitoring in Patients Implanted with HeartMate 3 Ventricular Assist Device	19
End Stage Heart Failure in Systemic Sclerosis- From Mechanical Circulatory Support to Heart Transplant	19
Single Nuclei Transcriptomic Analysis of Heart Allograft Ischemia-Reperfusion in a Rat Model	19
A Bold Look: Evaluation of Skeletal Muscle Microvascular Function in Pediatric Heart Transplant Recipients Using Post-Contractile Blood Oxygen Level Dependent MRI	19
Donor Factors Contributing to the Increase in Adult Heart Transplant Volume in the United States	18
Global Outcomes with Extended Criteria Donors When Preserved at 4-8°C: An Updated Analysis of the International GUARDIAN Heart Registry	18
Social Determinants of Health, Race and Their Relationship to Time in Therapeutic INR Range Following LVAD Implantation	18
Outcomes in Children Supported with Paracorporeal Continuous Compared to Paracorporeal Pulsatile Ventricular Assist Devices	18
Effect of Heparin Coated ECMO Circuit on AntiPF4 Antibodies	18
Mollicute Infections in Lung Transplant Patients: A Retrospective Review of Recipient Infections Post Initiation of a Screening Protocol	18
Impact of Logistic Challenges on Cardiac Transplantation	18
Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Acute Decompensated Heart Failure	18
Duration of Donor Cardiac Downtime in Donors After Circulatory Death Transplant	18
Survival After Combined Lung and Liver Transplantation: A 22-year Single-Centre Retrospective Study	18
Enhancing Post-Lung Transplant Care with AlloHome: Early Impact Evaluation	17
Improved Oxygenation and Atelectasis in Brain-Dead (BD) Donors with a Novel Percutaneous Transvenous Phrenic Nerve Stimulator	17
Cold Blood Cardioplegia Use for Cardiac Arrest After Heart Transportation with Organ Care System May Improve Outcomes	17
Letermovir Use for Cytomegalovirus Prophylaxis in Lung Transplant Recipients	17
SRC Homology and Collagen (Shc) Inhibition: A Novel Therapeutic Strategy for Transplant-Related Pulmonary Fibrosis	17
Early Detection of Baseline Lung Allograft Dysfunction: The Concept of Pre-BLAD	17
New Rules, Improved Results: Successful Outcomes Bridging Patients Listed Status 1 for Heart Transplantation	17
Outcomes After Heart Transplantation from Donors After Circulatory Death versus Brain Death: A Systematic Review and Meta-Analysis	17
The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients	17
Conversion from Immediate Release Tacrolimus to LCP-Tacrolimus in Heart Transplant Recipients	17
Comparing the Outcomes of Combined Heart-Liver Transplant Recipients from DCD and Non-DCD Donors: An Analysis Using the UNOS Database	17
Backwash Maneuver in LVAD Inflow Thrombosis: A Single-Center Experience (2015-2024)	17
Lung Transplantation for Primary Ciliary Dyskinesia - A Single Center Review	17
Immunologic Outcomes Following Mycophenolate Dose Reduction in Lung Transplant Recipients	17
Early Outcomes from the Use of Thoracic Epidural Analgesia versus INC Cryoablation during Lung Transplantation - A Single Center Experience	17
Acute Myocarditis: Trying to Dissect Potential Prognostic Factors	16
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion	16
Normothermic Ex Vivo Lung Perfusion (Novel) as an Assessment of Extended Criteria Donor Lungs: A Prospective Multi-Center Clinical Trial	16

MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4/PD-1 pathway through the metabolic-epigenetic nexus	16
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure	16
Sternal Closure After Clamshell Thoracotomy for Bilateral Lung Transplantation: Comparison Between Different Techniques	16
First North American Experience with The Berlin Heart Active Driver	16
Pediatric Heart Transplantation in Donation After Circulatory Death Using Normothermic Regional Perfusion - Early Experience with Small Donors	16
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep	16
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection	16
Pharmacist Managed Timing of Peri-Operative Plasmapheresis and Anti-Thymocyte Globulin in Heart Transplantation	16
A rare case of late onset tacrolimus-induced leukoencephalopathy and coma after pediatric orthotopic heart transplantation	16
Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation	16
Optimizing the handling of missing data in the UNOS database	16
Lung Ultrasound for Diagnosis of Primary Graft Dysfunction in Lung Transplantation Recipients	15
(324) Stanford Pediatric Psychosocial Optimization Tool for Transplant	15
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis	15
Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant	15
Risk of Prolonged Intubation Post-Pediatric Heart Transplantation	15
CD38 Antibody Daratumumab as an Add-On Rescue Therapy for AMR - First Report in Clinical Lung Transplantation	15
Donor sequence number is not associated with worse lung transplant outcomes regardless of transplant center case volume	15
The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients	15
“Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World”	15
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation	15
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study	15
Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine	15
Dapagliflozin Use in Children with Heart Failure Undergoing Heart Transplantation	15
Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study	15
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation	15
Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study	15
Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes	15
Towards a nuanced understanding of donor risk	15
Incidence and Risk Factors for Early Stroke Following Durable Left Ventricular Assist Device (LVAD) Implantation: An STS Intermacs Analysis	15
Evaluation of 10°C as the optimal storage temperature for aspiration-injured donor lungs in a large animal transplant model	14
(771) Post-Implant Outcomes in Diabetic vs. Non-Diabetic Durable LVAD Patients	14
The United States Experience of Lung Transplantation in Recipients with COVID-19 Fibrosis: A UNOS/OPTN Analysis	14
(1191) Diagnostic Utility of Surveillance Transbronchial Biopsies after the First Post-Lung Transplant Year	14
Life on the driveline: Still finding traction in improving transplant outcomes for children with myocarditis	14
Selection of lung transplant candidates: A pediatric perspective on the International Society for Heart and Lung Transplantation consensus document	14
(817) Lvad-Stem Cell Combination Therapy in Non-Ischemic Dilated Cardiomyopathy Patient: Case Report	14
Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension	14
Successful heart transplants from over 2000 miles away	14
The Role of Anti-Thymocyte Globulin in Peri-Operative Desensitization for Donor Specific Antibody Positive Lung Transplants	14
Care Close to Home: Justification for a Second Paediatric Heart Transplant Centre in Australia	14
I got it from my mamma: Sensitization by transplacental transfer of maternal HLA antibodies managed with manual exchange transfusion	14
Rapid progression of cardiac remodeling and apical wall thinning in early age with hypertrophic cardiomyopathy	14
Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial	14
Donor-Derived Cell-Free DNA as a Biomarker for the Effect of Daratumumab in Patients with Antibody-Mediated Rejection Post-Heart Transplant	14
Gentle Giant: An Unusual Cause of Heart Block	14
Standardized Radiographic Evaluation of Human Donor Lungs During Ex Vivo Lung Perfusion Predicts Lung Injury and Lung Transplant Outcomes	14
Extended survival of 9- and 10-gene-edited pig heart xenografts with ischemia minimization and CD154 costimulation blockade-based immunosuppression	14
Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial	14
Artificial Intelligence for the Prognostication and Management of Heart Transplant: A Scoping Review	14
Longitudinal analysis left ventricular chamber responses under durable LVAD support	14
Development of De-Novo Aortic Insufficiency in Patients with Durable Left Ventricular Assist Device Who Were Bridged from Impella Device	13
Peri-Operative Warfarin Protocol to Decrease Length of Stay After Left Ventricular Assist Device Implantation	13
Eplet Matching in Pediatric Heart Transplantation	13
(612) Using the SCAI Classification for Early Identification and Real-Time Monitoring of Cardiogenic Shock Patients	13
(647) Utilization of Hepatitis C Virus Infected Donor in Heart Transplant Recipients with Elevated Meld-Xi Score	13
(550) A Retrospective Study on Gender, LAA Morphology and Stroke Risk	13
(559) Heart Transplantation Using Super Aged Donors at 65 Years and Over	13
(826) Dual VADs to Dual Organs: Successful Bridge to Heart and Kidney Transplantation with 2 HeartMate 3 LVADs in Biventricular Failure	13
(634) Is Off-Pump Coronary Bypass Surgery the Savior of Low EF Coronary Artery Disease Patients?	13
Low AlloSure® in HeartCare® Associated with Low Risk of Significant Allograft Rejection: An Analysis of SHORE	13
VAD as Bridge to Transplant Decision in Nine-Year-Old Child with Duchenne Muscular Dystrophy	13
A Rare Case of ACE Inhibitor-Induced Intestinal Angioedema Presenting as a Delayed Complication in a Heart Transplant Recipient	13
Pulmonary Dead Space Fraction: A Predictive Factor for Transplant Suitability in Clinical Ex Vivo Lung Perfusion	13
Scimitar Syndrome Outcomes in Patients with Pulmonary Hypertension: A Single Center Experience	13
(686) West Nile Virus Meningoencephalitis in a Bilateral Lung Transplant Recipient	13
Proposal for Simplified Endoscopic Standardized Grading of Central Airway Complications After Lung Transplantation According to the Long-Term Prognosis Value of the Current MDS Classification	12
(956) Chronic in Vivo Animal Data on a Wireless Systolic Synchronized Mini-Cardiac Pump	12
(691) Right Heart Recovery after Lung Transplantation in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome: A Cohort Study	12
(711) Capillary Leak Syndrome Induced by Tacrolimus in Post-Lung Transplant Recipient	12
Long-Term Weaning of Mechanical Ventilation After Lung Transplantation: Patient Characteristics and Impact on Survival	12
(921) Effect of Surgical Exposure on Short-Term Outcomes after Bilateral Lung Transplantation	12
Donor and Peri-Transplant Hospitalization Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients	12
(933) Mechanical Circulatory Support as a Weaning Platform from Extracorporeal Membrane Oxygenation	12
Outcomes of Mechanical Circulatory Support for Severe Primary Graft Dysfunction After DBD versus DCD Heart Transplantation	12
Body Mass Index and Cause-Specific Mortality After Lung Transplantation in the United States	12
(859) Concurrent Tracheobronchoplasty and Bilateral Lung Transplant for Obstructive Lung Disease	12
Risks and Outcomes Associated with Pleural Space Infections After Lung Transplantation	12
Using mTOR Inhibitor Nanoimmunotherapy to Induce Cardiac Allograft Tolerance in Non-Human Primates	12
(916) Lung Transplant Outcomes in Young Adults with Pulmonary Hypertension Bridged with ECMO	12
(730) Continuous Temperature Measurements in Donor Hearts During Cold Organ Procurement	12
Longitudinal Echocardiographic Assessment of Donor Hearts in DCD Donors Using Thoracoabdominal Normothermic Regional Perfusion	12
PET Scan for CAV Screening in Heart Transplant Patients: A Real World Experience	12
(179) Clinical Predictors of 5-year Outcomes Following Heartmate 3 Left Ventricular Assist Device Implant: The Momentum 3 Trial	11
(1036) Through the "Chimney": Berlin Heart Excor Pediatric Ventricular Assist Device Inflow Stenting via a Novel Direct Access to Inflow Tubing	11
Variability in Donor-Derived Cell-Free DNA Levels Predicts Mortality Risk in Heart Transplant Recipients	11
(487) Use of Leadless Cardiac Pacemakers in Heart Transplant Recipients: A Case Series	11
(439) Severe Biventricular Dysfunction Following Pericardiectomy in a Pediatric Patient	11
(1014) Super Accelerated Cardiac Allograft Vasculopathy	11
Effect of Donor Age on Posttransplant Mortality in Pediatric Heart Transplant Recipients: A 10-Year Nationwide Cohort Study	11
(370) Genetic Signature of Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study	11
Pulmonary Artery Pressures During Cardiopulmonary Exercise Testing Using Cardiomems	11
Small Anastomotic Dehiscence Identified Late After Lung Transplant	11
ACEi Use in Select Patients Awaiting Heart Transplant May Be a Risk Factor for the Development of Primary Graft Dysfunction and Vasoplegia	11
(1013) The Dilemma of the Role of Non-HLA Antibodies in AMR	11